Whilst biotech companies are rushing to bring transformative gene therapies to market, states are too slow on adopting screening tests for genetic diseases that are, increasingly, treatable.
The advancement of sequencing technology has had the singe biggest effect on genomics research. As it develops further, so does the scope of genomic research and applications.
Michigan based researchers identify long noncoding RNA transcript as important molecule in prostate cancer progression. If you’re new to noncoding RNAs and cancer, this might be useful to read first!
A new technique reveals the earliest stages of human development without the need for human embryos.
In this open discussion webinar, DNA Genotek and Illumina discuss what’s trending in whole genome sequencing (WGS).
A new analysis of DNA sequences suggests the Native American founding population that migrated from Siberia consisted of approximately 250 people.
Illumina has revealed that it has acquired Edico Genome, with the intention of building on the solid foundation of DRAGEN, to deliver a more streamlines sample for customers.
For those planning to become parents, advances in sequencing technologies could make preconception carrier screening more useful by looking at a much broader set of genes.
Under the settlement agreement, Oxford Nanopore will refrain from offering its 2D sequencing products in the UK and Germany through the end of 2023.
Geisinger Health System CEO, Dr. David Feinberg reveals health system’s pioneering precision health efforts will be recommended to every patient.
MIT researchers have discovered, for the first time, the factors that determine whether a DNA knot moves along the strand or “jams” in place.
SOPHiA GENETICS, has announced that its technology for clinical genomics has reached a key milestone in helping better diagnose 200’000 patients. Already deployed in over 430 hospitals across 60 countries SOPHiA analyses today 1 patient every 5 minutes.
Harvard scientist, George Church is putting his efforts into using an alternative, older technology in a bid to recode an entire human genome in hundreds of thousands of locations in order to make it immune to viruses.
The National Insitute of Health is finally launching All of Us, a huge research study with the aim of making precision medicine available to people of all backgrounds. But will people give up their data?
The Scripps Translational Science Institute has received over $34 million in renewed funding from the National Institutes of Health’s National Center for Advancing Translational Sciences to advance medical research and clinical care through genomic and digital technologies.